Towa Pharmaceutical Co., Ltd. (TYO:4553)

Towa Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	29,252	29,650	24,257	32,830	22,915	18,713
Cash & Short-Term Investments	29,252	29,650	24,257	32,830	22,915	18,713
Cash Growth	-4.72%	22.23%	-26.11%	43.27%	22.45%	-41.08%
Receivables	79,023	71,657	54,392	50,748	45,784	41,572
Inventory	109,103	101,072	92,927	72,701	60,951	50,415
Other Current Assets	20,397	15,339	11,414	10,585	7,640	9,675
Total Current Assets	237,775	217,718	182,990	166,864	137,290	120,375
Property, Plant & Equipment	165,864	153,642	127,004	100,857	85,898	79,330
Long-Term Investments	846	3,006	3,104	3,035	3,277	6,447
Goodwill	29,306	32,568	34,613	44,647	7,050	10,209
Other Intangible Assets	17,986	18,018	18,332	9,455	7,913	7,441
Long-Term Deferred Tax Assets	-	5,699	5,303	5,075	4,239	4,336
Other Long-Term Assets	7,227	2	1	2	1	-
Total Assets	459,004	430,653	371,347	329,935	245,668	228,138
Accounts Payable	19,337	26,372	36,070	29,076	23,168	20,732
Accrued Expenses	-	96	117	108	100	54
Short-Term Debt	4,700	6,927	15,224	52,762	3,486	23,962
Current Portion of Long-Term Debt	10,869	10,120	7,527	12,172	7,181	6,767
Current Portion of Leases	1,151	-	-	-	-	-
Current Income Taxes Payable	3,176	23,911	14,012	15,536	12,069	12,466
Other Current Liabilities	39,456	12,692	5,579	5,419	5,512	5,487
Total Current Liabilities	78,689	80,118	78,529	115,073	51,516	69,468
Long-Term Debt	197,083	189,124	150,314	79,194	74,098	51,664
Other Long-Term Liabilities	4,363	5,299	5,288	2,952	2,916	1,993
Total Liabilities	289,981	274,761	234,453	197,766	129,070	123,489
Common Stock	4,717	4,717	4,717	4,717	4,717	4,717
Additional Paid-In Capital	7,841	7,838	7,837	7,837	7,834	7,870
Retained Earnings	146,140	134,452	121,232	122,131	108,629	97,171
Treasury Stock	-5,586	-5,606	-5,608	-5,608	-5,626	-5,627
Comprehensive Income & Other	15,911	14,491	8,716	3,092	1,044	518
Shareholders' Equity	169,023	155,892	136,894	132,169	116,598	104,649
Total Liabilities & Equity	459,004	430,653	371,347	329,935	245,668	228,138
Total Debt	223,479	206,171	173,065	144,128	84,765	82,393
Net Cash (Debt)	-194,227	-176,521	-148,808	-111,298	-61,850	-63,680
Net Cash Per Share	-3945.85	-3586.33	-3023.21	-2211.60	-1206.18	-1197.58
Filing Date Shares Outstanding	49.23	49.22	49.22	49.22	49.21	49.21
Total Common Shares Outstanding	49.23	49.22	49.22	49.22	49.21	49.21
Working Capital	159,086	137,600	104,461	51,791	85,774	50,907
Book Value Per Share	3433.54	3167.24	2781.16	2685.17	2369.18	2126.40
Tangible Book Value	121,731	105,306	83,949	78,067	101,635	86,999
Tangible Book Value Per Share	2472.85	2139.49	1705.52	1586.02	2065.14	1767.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.